Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 4, 2009, Pages 382-387

  Katsarou, A ^a   Armenaka, M ^a   Vosynioti, V ^a   Lagogianni, E ^a   Kalogeromitros, D ^a   Katsambas, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Allergens; Allergic contact dermatitis; Eyelid; Patch testing; Periorbital; Tacrolimus; Therapy

Indexed keywords

TACROLIMUS;

ADULT; AGED; ALLERGIC BLEPHARITIS; APPLICATION SITE BURNING; APPLICATION SITE PRURITUS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; EYELID EDEMA; FEMALE; HUMAN; LICHENOID ERUPTION; MALE; OPEN STUDY; PRIORITY JOURNAL; PRURITUS; SKIN ALLERGY; SKIN BURNING SENSATION; SKIN FISSURE;

ADULT; AGED; DERMATITIS, CONTACT; EYELID DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OINTMENTS; TACROLIMUS;

EID: 62149147507     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.03056.x     Document Type: Article

References (25)

1. Shah M, Lewis FM, Gawkrodger DJ. Facial dermatitis and eyelid dermatitis: a comparison of patch test results and final diagnoses. Contact Dermatitis 1996 34 : 140 141.
2. Ayala F, Fabbrocini G, Bacchilega R et al. Eyelid dermatitis: an evaluation of 447 patients. Am J Contact Dermatitis 2003 14 : 69 74.
3. Mills CM, Marks R. Side effects of the topical glucocorticosteroids. Curr Probl Dermatol 1993 21 : 122 131.
4. Fukaya M. Why do patients with atopic dermatitis refuse to apply topical corticosteroids? Dermatology 2000 201 : 242 245.
5. Garrott HM, Walland MJ. Glaucoma from topical corticosteroids to the eyelids. Clin Exp Opthalmol 2004 32 : 224 226.
6. Bekersky I, Fitzsimmons W, Tanase A, Mahjer R, Hodosh E, Lawrence I. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 2001 44 : S17 S27.
7. Panhans-Gross A, Novak N, Kraft S, Bieber T. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK 506). J Allergy Clin Immunol 2001 107 : 345 352.
8. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine A and FK506. Immunol Today 1992 13 : 136 142.
9. Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment (Protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis 2003 49 : 185 188.
10. Lachepelle JM. A proposed relevance scoring system for positive allergic patch test reactions: practical implications and limitations. Contact Dermatitis 1997 36 : 39 43.
11. Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis 1986 14 : 221 227.
12. Valsecchi R, Imberti G, Martano D, Cainelli T. Eyelid dermatitis: an evaluation of 150 patients. Contact Dermatitis 1992 27 : 143 147.
13. Foti C, Seidenari S, Antelmi A, Bonamonte D, Conserva A, Angelini G. Provocation use test of 1 euro coin in nickel-sensitized subjects. Contact Dermatitis 2005 52 : 167 168.
14. Sahni D, Darley CR, Hawk JL. Glaucoma induced by periorbital topical steroid use - a rare complication. Clin Exp Dermatol 2004 29 : 617 619.
15. Cheer SM, Plosker GL. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Dermatol 2001 2 : 389 406.
16. Schachner LA, Lamerson C, Sheehan MP et al. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double blind, vehicle-controlled study. Pediatrics 2005 116 : 334 342.
17. Freeman AK, Serle J, VanVeldhuisen P et al. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis 2004 73 : 267 271.
18. Lauerma Al, Maibach HI, Granlund H, Erkoo P, Kartamaa M, Stubb S. Inhibition of contact allergy reactions by topical FK506. Lancet 1992 340 : 556.
19. Saripalli YV, Gadzia JE, Belsito DV. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol 2003 49 : 477 482.
20. Nakada T, Iijima M, Maibach H. Eyeglass frame allergic contact dermatitis: does tacrolimus prevent recurrences? Contact Dermatitis 2005 53 : 219 221.
21. Pacor ML, Di Lorenzo G, Martinelli N et al. Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. Allergy Asthma Proc 2006 27 : 527 531.
22. Elston DM. Topical macrolactams: new indications, potential pitfalls. (editorial). Cutis 2004 73 : 225 226.
23. Shaw DW, Maibach HI, Eichenfield LE. Allergic contact dermatitis from pimecrolimus in a patient with a tacrolimus allergy. J Am Acad Dermatol 2007 56 : 342 345.
24. Protopic. SPC. Annex 1. Summary of product characteristics (pp. 12 17). http://www.emea.europa.eu/humandocs/PDFs/EPAR/protopic/ProtopicSPC.pdf.
25. Prograf. Astellas Pharma Ltd, SPC from the eMC (pp. 8 14). http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=11102.